It's a company full of entry level positions with a high turn over rate - Implementation Specialist Meditech Employee Review

3.0
May 24, 2012
Recommend
CEO approval
Business Outlook

Pros

The company overall is very stable. In their 60+ years of existence, they've never had a layoff or salary cuts. The benefits are great, you hardly pay anything for top of the line health care. If you plan on staying with the company long term, then you become vested, and basically have the ability to buy stock in the company which is their version of a 401(K), which they don't offer. Also, at the end of the year you get cash bonuses that are based on how much the company makes, as well as how much you made for the year.

Cons

They only promote from within, which is a great concept, but actually ends up hurting them. Many of the supervisors and managers weren't promoted because they were good at their jobs, but because they've been with the company for so long. The starting salaries are very low for this field, but I guess job stability kind of makes up for it. The raise scale is also pretty antiquated. The worst part about the company would be the phones though, and if you work here, you know why. Also, there is a fairly high turn over rate, the company is pretty much a revolving door.

Explore other reviews about Meditech

5.0
Nov 23, 2025
Recommend
CEO approval
Business Outlook

Pros

Pretty good environment to work in

Cons

A lot of travel which is both good and bad

2.0
Jul 12, 2026
Recommend
CEO approval
Business Outlook

Pros

MEDITECH is surviving, which wasn't a certainty ten years ago. Considering the low starting salaries for greater Boston, the company tends to be less selective in who they hire compared to other employers. Even with the effect that AI is having on tech hiring.

Cons

The market was MEDITECH's to lose, and they lost it. Without HCA as a customer MEDITECH would be finished. Considerations for job applicants such as inclusiveness and work/life balance are largely irrelevant, as the company's long-term prospects for success are doubtful. MaaS subscriptions don't bring in enough money to make up for the business that was lost to market leader Epic Systems. I am a MEDITECH shareholder, so I see the financial reports. Although I'm pleased that dividends continue to be paid, they are draining the company of badly needed cash to fund a turnaround.

4
See reviews by: Helpful|Rating|Date|All